Natelle One (Azur Pharma, Inc.)


Welcome to the PulseAid listing for the Natelle One drug offered from Azur Pharma, Inc.. This Calcium [Chemical/Ingredient],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Azur Pharma, Inc.
NON-PROPRIETARY NAME: Natelle One
SUBSTANCE NAME: DOCONEXENT; ICOSAPENT; TRICALCIUM PHOSPHATE; FERROUS FUMARATE; ASCORBIC ACID; PYRIDOXINE HYDROCHLORIDE; ALPHA-TOCOPHEROL, D-; FOLIC ACID
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Calcium [Chemical/Ingredient],Calcium [EPC],Phosphate Binder [EPC],Phosphate Chelating Activity [MoA],Vitamin B6 Analog [EPC],Vitamin B 6 [Chemical/Ingredient],Analogs/Derivatives [Chemical/Ingredient]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: UNAPPROVED DRUG OTHER
START MARKETING DATE: 2009-11-09
END MARKETING DATE: 0000-00-00


Natelle One HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNatelle One from Azur Pharma, Inc.
LABELER NAME: Azur Pharma, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 250; .625; 100; 27; 30; 25; 30; 1(mg/1; mg/1; mg/1; mg/1; mg/1; mg/1; [iU]/1; mg/1)
START MARKETING DATE: 2009-11-09
END MARKETING DATE: 0000-00-00
PRODUCT ID: 18860-852_06b963be-0817-469e-ad3a-8096324fbe94
PRODUCT NDC: 18860-852
APPLICATION NUMBER: na

Other DOCONEXENT; ICOSAPENT; TRICALCIUM PHOSPHATE; FERROUS FUMARATE; ASCORBIC ACID; PYRIDOXINE HYDROCHLORIDE; ALPHA-TOCOPHEROL, D-; FOLIC ACID Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Azur Pharma, Inc.Natelle One